Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients

Authors

  • Carmen Fiuza-Luces Research Institute Hospital 12 de Octubre (`i+12'), Madrid, Spain Author
  • Nuria Garatachea Research Institute Hospital 12 de Octubre (`i+12'), Madrid, Spain Author
  • Richard J. Simpson Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston, Houston, TX, USA Author
  • Nathan A. Berger Center for Science, Health and Society, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, USA Author
  • Manuel Ramírez Hospital Infantil Universitario Nino Jesus, Madrid, Spain Author
  • Alejandro Lucia Research Institute Hospital 12 de Octubre (`i+12'), Madrid, Spain Author

DOI:

https://doi.org/10.22029/eir.2015.1698

Keywords:

STEROID-REFRACTORY ACUTE, BONE-MARROW-TRANSPLANTATION, STEM-CELL TRANSPLANTATION, QUALITY-OF-LIFE, CONSENSUS DEVELOPMENT PROJECT, MINOR HISTOCOMPATIBILITY ANTIGENS, REGULATORY T-CELLS, GROWTH-FACTOR-BETA, LOW-DOSE METHOTREXATE, MONOCLONAL-ANTIBODY TREATMENT

Abstract

Advances in this century regarding allogeneic hematopoietic stem cell transplantation (allo-HSCT) have led to an expanding population of long-term survivors, many of whom suffer severe side effects. particularly those related to graft-versus-host disease (GVHD), a potentially multi-systemic disorder caused by immunoeffector donor lymphocytes that destroy host tissues. The GVHD, especially in its chronic form (cGVHD) generates considerable morbidity and compromises the physical capacity of patients. We have reviewed the main pathophysiological aspects of the disease as well as the data available on the effects of exercise in GVHD, based on animal and human patient research. Although exercise training as an adjunct therapy to improve health outcomes after allo-HSCT shows promise (particularly, this lifestyle intervention can improve physical fitness and possibly immune function while attenuating fatigue), there is a need for, more randomized control trials that focus specifically on GVHD.

References

Downloads

Published

2015-12-31

Issue

Section

Articles